Skip to main content

Table 1 Demographic, clinical and laboratory characteristics of AML patients

From: Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

 

Normal range

Patients (n = 69)

Age (years)

 

59 ± 16

Gender

 Male

 

42 (61%)

 Female

 

27 (39%)

AML

 Primary

 

56 (81%)

  M0/M1/M2

 

32

  M3 (APL)

 

5

  M4/M5

 

19

  M6/M7

 

0

 Secondary

 

13 (19%)

  Post MDS

 

12

  Post MPN

 

1

Peripheral blasts (103/µL)

 

12 (2–30)

Platelets (103/µL)

150–400

47 (25–88)

Hemoglobin (g/dL)

12.3–15.3

9.6 ± 1.9

Prothrombin time (%)

80–130

79 ± 23

Fibrinogen (g/L)

1.8–4.0

4.3 ± 2.3

D-dimer (mg/L)

0.0–0.5

5.1 (1.6–22.1)

LDH (U/L)

84–246

474 (339–884)

  1. Data are presented as mean ± standard deviation or as median and interquartile range. AML subtypes are according to the French–American–British (FAB) classification.
  2. APL acute promyelocytic leukemia, LDH lactate dehydrogenase, MDS myelodysplastic syndrome, MPN myeloproliferative neoplasia.
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us